New hope for heart inflammation sufferers: experimental drug VTX2735 enters Mid-Stage trial
Disease control
Recruiting now
This study tests an experimental drug called VTX2735 in 50 adults with recurrent pericarditis, a condition where the heart's lining becomes inflamed and painful. The goal is to see if the drug is safe and can reduce pain and inflammation. Participants receive different doses over…
Phase: PHASE2 • Sponsor: Zomagen Biosciences Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC